A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Short-Acting β1-Adrenergic Receptor Blocker Landiolol Hydrochloride for Coronary Computed Tomography Angiography in Japanese Patients with Suspected Ischemic Cardiac Disease

Masaharu Hirano;  ; Akira Yamashina; Kazuhiro Hara; Yuji Ikari; Masahiro Jinzaki; Misako Iino; Takuhiro Yamaguchi; Mitsunobu Tanimoto; Sachio Kuribayashi

doi:10.1007/s40261-013-0149-y

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Short-Acting β1-Adrenergic Receptor Blocker Landiolol Hydrochloride for Coronary Computed Tomography Angiography in Japanese Patients with Suspected Ischemic Cardiac Disease

Clinical Drug Investigation ◽

10.1007/s40261-013-0149-y ◽

2013 ◽

Vol 34 (1) ◽

pp. 53-62 ◽

Cited By ~ 5

Author(s):

Masaharu Hirano ◽

◽

Akira Yamashina ◽

Kazuhiro Hara ◽

Yuji Ikari ◽

...

Keyword(s):

Computed Tomography ◽

Cardiac Disease ◽

Adrenergic Receptor ◽

Coronary Computed Tomography Angiography ◽

Japanese Patients ◽

Phase Iii ◽

Double Blind ◽

Double Blind Placebo ◽

Landiolol Hydrochloride ◽

Phase Iii Study

Download Full-text

A Multicenter, Open-Label Study of an Intravenous Short-Acting β1-Adrenergic Receptor Antagonist Landiolol Hydrochloride for Coronary Computed Tomography Angiography by 16-Slice Multi-Detector Computed Tomography in Japanese Patients with Suspected Ischemic Cardiac Disease

Drugs in R&D ◽

10.1007/s40268-014-0056-6 ◽

2014 ◽

Vol 14 (3) ◽

pp. 185-194 ◽

Cited By ~ 3

Author(s):

Masaharu Hirano ◽

◽

Akira Yamashina ◽

Kazuhiro Hara ◽

Yuji Ikari ◽

...

Keyword(s):

Computed Tomography ◽

Cardiac Disease ◽

Adrenergic Receptor ◽

Coronary Computed Tomography Angiography ◽

Japanese Patients ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Landiolol Hydrochloride ◽

Multi Detector Computed Tomography

Download Full-text

Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study

Allergology International ◽

10.1016/j.alit.2016.05.014 ◽

2017 ◽

Vol 66 (1) ◽

pp. 97-105 ◽

Cited By ~ 9

Author(s):

Kimihiro Okubo ◽

Minoru Gotoh ◽

Mikiya Asako ◽

Yasuyuki Nomura ◽

Michinori Togawa ◽

...

Keyword(s):

Allergic Rhinitis ◽

Japanese Patients ◽

Phase Iii ◽

Efficacy And Safety ◽

Perennial Allergic Rhinitis ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group ◽

Phase Iii Study

Download Full-text

Short-Term Efficacy (at 12 Weeks) and Long-Term Safety (up to 52 Weeks) of Omega-3 Free Fatty Acids (AZD0585) for the Treatment of Japanese Patients With Dyslipidemia　― A Randomized, Double-Blind, Placebo-Controlled, Phase III Study ―

Circulation Journal ◽

10.1253/circj.cj-19-0358 ◽

2020 ◽

Vol 84 (6) ◽

pp. 994-1003 ◽

Cited By ~ 1

Author(s):

Koutaro Yokote ◽

Kiyoshi Niwa ◽

Tomomi Hakoda ◽

Fumiki Oh ◽

Yoshitaka Kajimoto ◽

...

Keyword(s):

Fatty Acids ◽

Free Fatty Acids ◽

Japanese Patients ◽

Phase Iii ◽

Omega 3 ◽

Short Term ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study

Download Full-text

Efficacy and safety of canagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study

Expert Opinion on Pharmacotherapy ◽

10.1517/14656566.2014.935764 ◽

2014 ◽

Vol 15 (11) ◽

pp. 1501-1515 ◽

Cited By ~ 78

Author(s):

Nobuya Inagaki ◽

Kazuoki Kondo ◽

Toru Yoshinari ◽

Nahoko Takahashi ◽

Yutaka Susuta ◽

...

Keyword(s):

Type 2 Diabetes ◽

Japanese Patients ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Diet And Exercise ◽

Phase Iii Study

Download Full-text

A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC

Case Medical Research ◽

10.31525/ct1-nct04033354 ◽

2019 ◽

Author(s):

Keyword(s):

Stage Iiib ◽

Phase Iii ◽

Line Treatment ◽

Efficacy And Safety ◽

First Line ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

A Randomized, Double-blind, Placebo‑Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Case Medical Research ◽

10.31525/ct1-nct04063163 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

Extensive Stage

Download Full-text

Faculty Opinions recommendation of Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: a randomized, double-blind, placebo-controlled phase III study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717962498.793465528 ◽

2012 ◽

Author(s):

David Alpers

Keyword(s):

Peritoneal Carcinomatosis ◽

Bowel Obstruction ◽

Symptomatic Treatment ◽

Phase Iii ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study

Download Full-text

PIII-38Long-term effects of ramelteon on endocrine function in patients with chronic insomnia in a double-blind, placebo-controlled phase III study

Clinical Pharmacology & Therapeutics ◽

10.1016/j.clpt.2005.12.246 ◽

2006 ◽

Vol 79 (2) ◽

pp. P68-P68 ◽

Cited By ~ 5

Author(s):

G RICHARDSON ◽

S WANGWEIGAND ◽

S SAINATI ◽

S DEMISSIE

Keyword(s):

Endocrine Function ◽

Phase Iii ◽

Chronic Insomnia ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study

Download Full-text

Efficacy, safety, and gastrointestinal tolerability of tapentadol ER in a randomized, double-blind, placebo- and active-controlled phase III study of patients with chronic low back pain

Journal of Pain ◽

10.1016/j.jpain.2009.01.202 ◽

2009 ◽

Vol 10 (4) ◽

pp. S48 ◽

Cited By ~ 5

Author(s):

R. Buynak ◽

D. Shapiro ◽

A. Okamoto ◽

C. Lange ◽

M. Etropolski

Keyword(s):

Low Back Pain ◽

Back Pain ◽

Chronic Low Back Pain ◽

Phase Iii ◽

Low Back ◽

Double Blind ◽

Double Blind Placebo ◽

Gastrointestinal Tolerability ◽

Phase Iii Study

Download Full-text

72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension

Advances in Therapy ◽

10.1007/s12325-018-0788-8 ◽

2018 ◽

Vol 35 (10) ◽

pp. 1598-1611 ◽

Cited By ~ 9

Author(s):

Hirofumi Ochi ◽

Masaaki Niino ◽

Yasuhiro Onizuka ◽

Katsutoshi Hiramatsu ◽

Masakazu Hase ◽

...

Keyword(s):

Multiple Sclerosis ◽

Japanese Patients ◽

Dimethyl Fumarate ◽

Phase Iii ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo ◽

Relapsing Remitting ◽

Open Label Extension ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Short-Acting β1-Adrenergic Receptor Blocker Landiolol Hydrochloride for Coronary Computed Tomography Angiography in Japanese Patients with Suspected Ischemic Cardiac Disease

A Multicenter, Open-Label Study of an Intravenous Short-Acting β1-Adrenergic Receptor Antagonist Landiolol Hydrochloride for Coronary Computed Tomography Angiography by 16-Slice Multi-Detector Computed Tomography in Japanese Patients with Suspected Ischemic Cardiac Disease

Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study

Short-Term Efficacy (at 12 Weeks) and Long-Term Safety (up to 52 Weeks) of Omega-3 Free Fatty Acids (AZD0585) for the Treatment of Japanese Patients With Dyslipidemia ― A Randomized, Double-Blind, Placebo-Controlled, Phase III Study ―

Efficacy and safety of canagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study

A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC

A Randomized, Double-blind, Placebo‑Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Faculty Opinions recommendation of Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: a randomized, double-blind, placebo-controlled phase III study.

PIII-38Long-term effects of ramelteon on endocrine function in patients with chronic insomnia in a double-blind, placebo-controlled phase III study

Efficacy, safety, and gastrointestinal tolerability of tapentadol ER in a randomized, double-blind, placebo- and active-controlled phase III study of patients with chronic low back pain

72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension

Short-Term Efficacy (at 12 Weeks) and Long-Term Safety (up to 52 Weeks) of Omega-3 Free Fatty Acids (AZD0585) for the Treatment of Japanese Patients With Dyslipidemia　― A Randomized, Double-Blind, Placebo-Controlled, Phase III Study ―